Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/SANOFI-4698/actualite/Sanofi-annonce-l-approbation-par-la-FDA-d-AdlyxinTM-dans-le-traitement-du-diabete-de-type-2-chez-22764495/?utm_source=whatsapp&utm_medium=social&utm_campaign=share